These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 18959484)
41. Intellectual property issues in a clinical trial: a corporate perspective. Fersko RS; Connolly MJ Qual Assur; 1992 Jun; 1(3):237-48. PubMed ID: 1344679 [No Abstract] [Full Text] [Related]
42. Technology transfer at US universities: seeking public benefit from the results of basic research. Goodwin CD Technol Health Care; 1996 Sep; 4(3):323-30. PubMed ID: 8931243 [TBL] [Abstract][Full Text] [Related]
43. Intellectual property. Plants and intellectual property: an international appraisal. Koo B; Nottenburg C; Pardey PG Science; 2004 Nov; 306(5700):1295-7. PubMed ID: 15550646 [No Abstract] [Full Text] [Related]
44. US trade rules seek to balance health and patent protection. Wadman M; Cherry M Nature; 1999 Dec; 402(6762):567-8. PubMed ID: 10604448 [No Abstract] [Full Text] [Related]
45. Commercialization of Transplantation Research. Hutchinson JA Transplantation; 2016 May; 100(5):964-5. PubMed ID: 27116576 [No Abstract] [Full Text] [Related]
46. Accountability in patenting of federally funded research. Rai AK; Sampat BN Nat Biotechnol; 2012 Oct; 30(10):953-6. PubMed ID: 23051811 [TBL] [Abstract][Full Text] [Related]
47. Science and law. View from the bench: patents and material transfers. Walsh JP; Cho C; Cohen WM Science; 2005 Sep; 309(5743):2002-3. PubMed ID: 16179461 [No Abstract] [Full Text] [Related]
48. Increase competition to stabilize drug prices. Miller HI Science; 2001 Jul; 293(5528):213-4. PubMed ID: 11452976 [No Abstract] [Full Text] [Related]
49. Why did universities start patenting? Institution-building and the road to the Bayh-Dole Act. Berman EP Soc Stud Sci; 2008 Dec; 38(6):835-71. PubMed ID: 19227798 [TBL] [Abstract][Full Text] [Related]
50. Updating the Bayh-Dole Act: March-in Rights and Transparency. Cook-Deegan R; Kesselheim AS; Sarpatwari A JAMA; 2022 Mar; 327(10):923-924. PubMed ID: 35201276 [No Abstract] [Full Text] [Related]
52. Drug prices: real problem, wrong solution. Kennedy D Science; 2001 Jun; 292(5523):1797. PubMed ID: 11397914 [No Abstract] [Full Text] [Related]
53. The incorporation of new technologies into genetic services; the importance of government support. Holtzman NA Birth Defects Orig Artic Ser; 1992; 28(3):126-30. PubMed ID: 1489950 [No Abstract] [Full Text] [Related]
54. Regulating scientific research: intellectual property rights and the norms of science. Rai AK Northwest Univ Law Rev; 1999; 94(1):77-152. PubMed ID: 12784815 [No Abstract] [Full Text] [Related]
56. Science and the law. Working through the patent problem. Walsh JP; Cohen WM; Arora A Science; 2003 Feb; 299(5609):1021. PubMed ID: 12586928 [No Abstract] [Full Text] [Related]
57. Patenting the PKU test--federally funded research and intellectual property. Paul DB; Ankeny RA N Engl J Med; 2013 Aug; 369(9):792-4. PubMed ID: 23984725 [No Abstract] [Full Text] [Related]
58. Intellectual property. Indian government hopes bill will stimulate innovation. Bhattacharjee Y Science; 2008 Feb; 319(5863):556. PubMed ID: 18239095 [No Abstract] [Full Text] [Related]
59. Industry and academia in transition. Kennedy D Science; 2003 Nov; 302(5649):1293. PubMed ID: 14631000 [No Abstract] [Full Text] [Related]